André Ricardo Ribas Freitas

Dr. André Ricardo Ribas Freitas

Epidemiology, Faculdade São Leopoldo Mandic, Campinas, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Revista de Saúde Pública
Verified
Journal Article
Open access
PDF file
MDMaria Rita Donalisio
Maria Rita Donalisio
André Ricardo Ribas FreitasAndré Ricardo Ribas Freitas
André Ricardo Ribas Freitas
AZAndrea Paula Bruno Von Zuben
Andrea Paula Bruno Von Zuben
Arboviruses have been emerging in different parts of the world due to genetic changes in the virus, alteration of the host and vector population dynamics, or because of anthropogenic environmental factors. These viruses’ capacity for adaptation is notable, as well as the likelihood of their emergence and establishment in new geographic areas. In Brazilian epidemiologic scenario, the most common arboviruses are DENV, CHIKV, and ZIKV, although others may spread in the country. Little is yet known of the impact of viral co-circulation, which would theoretically result in more intense viremia or other immunological alterations that could trigger autoimmune diseases, such as Guillain-Barré syndrome. The impact on morbidity and mortality intensifies as extensive epidemics lead to a high number of affected individuals, severe cases, and implications for health services, mainly due to the absence of treatment, vaccines, and effective prevention and control measures.

1 April 2020 in Epidemiologia e Serviços de Saúde
Verified
Journal Article
Open access
PDF file
André Ricardo Ribas FreitasAndré Ricardo Ribas Freitas
André Ricardo Ribas Freitas
MNMarcelo Napimoga
Marcelo Napimoga
MDMaria Rita Donalisio
Maria Rita Donalisio
O Plano de Influenza Pandêmica (Pandemic Influenza Plan - PIP), elaborado pelo Departamento de Saúde e Serviços Humanos (Department of Health and Human Services3 dos Estados Unidos, em sua quarta atualização, publicada no ano de 2017, incluiu medidas para diferentes áreas do governo e da sociedade civil. Além disso, para que a resposta seja proporcional à gravidade da situação, usa o Quadro de Avaliação da Gravidade Pandêmica (Pandemic Severity Assessment Framework - PSAF)4 como ferramenta de avaliação de risco.

30 May 2017 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
YKYiu-Wing Kam
Yiu-Wing Kam
JLJuliana Almeida Leite
Juliana Almeida Leite
FLFok-Moon Lum
Fok-Moon Lum
JTJeslin J L Tan
Jeslin J L Tan
BLBernett Lee
Bernett Lee
FCFabio T M Costa
Fabio T M Costa
Zika virus (ZIKV) infections have been linked to different levels of clinical outcomes, ranging from mild rash and fever to severe neurological complications and congenital malformations. We investigated the clinical and immunological response, focusing on the immune mediators profile in 95 acute ZIKV-infected adult patients from Campinas, Brazil. These patients included 6 pregnant women who later delivered during the course of this study. Clinical observations were recorded during hospitalization. Levels of 45 immune mediators were quantified using multiplex microbead-based immunoassays. Whereas 11.6% of patients had neurological complications, 88.4% displayed mild disease of rash and fever. Several immune mediators were specifically higher in ZIKV-infected patients, and levels of interleukin 10, interferon gamma-induced protein 10 (IP-10), and hepatocyte growth factor differentiated between patients with or without neurological complications. Interestingly, higher levels of interleukin 22, monocyte chemoattractant protein 1, TNF-α, and IP-10 were observed in ZIKV-infected pregnant women carrying fetuses with fetal growth–associated malformations. Notably, infants with congenital central nervous system deformities had significantly higher levels of interleukin 18 and IP-10 but lower levels of hepatocyte growth factor than those without such abnormalities born to ZIKV-infected mothers. This study identified several key markers for the control of ZIKV pathogenesis. This will allow a better understanding of the molecular mechanisms of ZIKV infection in patients.

Verified
Journal Article
Open access
PDF file
LCLourrany Borges Costa
Lourrany Borges Costa
FBFrancisca Kalline de Almeida Barreto
Francisca Kalline de Almeida Barreto
MBMarina Carvalho Arruda Barreto
Marina Carvalho Arruda Barreto
TSThyago Henrique Pereira dos Santos
Thyago Henrique Pereira dos Santos
MAMaria de Margarette Oliveira de Andrade
Maria de Margarette Oliveira de Andrade
Luciano Pamplona de Góes CAVALCANTILuciano Pamplona de Góes CAVALCANTI
Luciano Pamplona de Góes CAVALCANTI
Chikungunya (CHIK) is a re-emerging viral infection endemic in tropical and subtropical areas. While the typical clinical presentation is an acute febrile syndrome, long-term articular complications and even death can occur. This review characterizes the global epidemiological and economic burden of chikungunya. The search included studies published from 2007 to 2022 in MEDLINE, Embase, LILACS, and SciELO for a thorough evaluation of the literature. Rayyan software was used for data analysis, and data were summarized descriptively and reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Seventy-six publications were included. Chikungunya is widely distributed in the tropics, including Africa, Asia, South America, and Oceania/the Pacific Islands, and co-circulates with other simultaneous arboviruses such as DENV, ZIKV, and YFV. Chikungunya infection can lead to chronic articular manifestations with a significant impact on the quality of life in the long term. In addition, it generates absenteeism and economic and social losses and can cause fatal infections in vulnerable populations, mainly in high-risk patients with co-morbidities and at the extremes of age. Reported costs associated with CHIKV diseases are substantial and vary by region, age group, and public/private delivery of healthcare services. The chikungunya disease burden includes chronicity, severe infections, increased hospitalization risks, and associated mortality. The disease can impact the economy in several spheres, significantly affecting the health system and national economies. Understanding and measuring the full impact of this re-emerging disease is essential.

2 July 2021 in The Lancet Regional Health - Americas
Verified
Journal Article
Open access
André Ricardo Ribas FreitasAndré Ricardo Ribas Freitas
André Ricardo Ribas Freitas
OBOtto Albuquerque Beckedorff
Otto Albuquerque Beckedorff
LCLuciano Pamplona de Góes Cavalcanti
Luciano Pamplona de Góes Cavalcanti
ASAndre M. Siqueira
Andre M. Siqueira
DCDaniel Barros de Castro
Daniel Barros de Castro
EBEliana N.C. Barros
Eliana N.C. Barros
Since the end of 2020, there has been a great deal of international concern about the variants of SARS-COV-2 B.1.1.7, identified in the United Kingdom; B.1.351 discovered in South Africa and P.1, originating from the Brazilian state of Amazonas. The three variants were associated with an increase in transmissibility and worsening of the epidemiological situation in the places where they expanded. The lineage B.1.1.7 was associated with the increase in case fatality rate in the United Kingdom. There are still no studies on the case fatality rate of the other two variants. The aim of this study was to analyze the mortality profile before and after the emergence of the P.1 strain in the Amazonas state. We analyzed data from the Influenza Epidemiological Surveillance Information System, SIVEP-Gripe (Sistema de Informação de Vigilância Epidemiológica da Gripe), comparing two distinct epidemiological periods: during the peak of the first wave, between April and May 2020, and in January 2021 (the second wave), the month in which the new variant came to predominate. We calculated mortality rates, overall case fatality rate and case fatality rate among hospitalized patients; all rates were calculated by age and gender and 95% confidence intervals (95% CI) were determined. We observed that in the second wave there were a higher incidence and an increase in the proportion of cases of COVID-19 in the younger age groups. There was also an increase in the proportion of women among Severe Acute Respiratory Infection (SARI) cases from 40% (2,709) in the first wave to 47% (2,898) in the second wave and in the proportion of deaths due to COVID-19 between the two periods varying from 34% (1,051) to 47% (1,724), respectively. In addition, the proportion of deaths among people between 20 and 59 years old has increased in both sexes. The case fatality rate among those hospitalized in the population between 20 and 39 years old during the second wave was 2.7 times the rate observed in the first wave (female rate ratio = 2.71; 95% CI: 1.9-3.9], p <0.0001; male rate ratio = 2.70, 95%CI:2.0-3.7), and in the general population the rate ratios were 1.15 (95% CI: 1.1-1.2) in females and 0.78 (95% CI: 0.7-0.8) in males]. Based on this prompt analysis of the epidemiological scenario in the Amazonas state, the observed changes in the pattern of mortality due to COVID-19 between age groups and gender simultaneously with the emergence of the P.1 strain suggest changes in the pathogenicity and virulence profile of this new variant. Further studies are needed to better understanding of SARS-CoV-2 variants profile and their impact for the health population. There was no funding for this study.

28 November 2024 in New England Journal of Medicine
Verified
Journal Article
Closed access
CFCarlos Garcia Filho
Carlos Garcia Filho
ANAntônio Silva Lima Neto
Antônio Silva Lima Neto
AMAna Maria Peixoto Cabral Maia
Ana Maria Peixoto Cabral Maia
LSLuiz Osvaldo Rodrigues da Silva
Luiz Osvaldo Rodrigues da Silva
RCRobson da Costa Cavalcante
Robson da Costa Cavalcante
LCLuciano Pamplona de Góes Cavalcanti
Luciano Pamplona de Góes Cavalcanti